ATG9A and neoplasm: Given that ATG9A deficiency in tumor leads to increased inflammatory cytokine secretion, we aimed to characterize the tumor associated and cytotoxic macrophages in control and ATG9A KO tumors in vivo, which may have mechanistic and therapeutic relevance.